Race to the bottom
Pricing policies threaten pharmaceutical makers.
By
Jerry Isaacson
Latest articles
All Articles
Revenues fall off the patent cliff, rain down on generics firms.
When patents run out, generic pharmaceutical companies reap the benefits.
By